Skip to main content

Zhong Lun Law Firm and O’Melveny & Myers have advised Chinese drug development service provider Pharmaron on its $588 million Hong Kong initial public offering, with JunHe and Skadden, Arps, Slate, Meagher & Flom advising the joint sponsors.

According to a press release, Pharmaron, based in Beijing and founded in 2004, is a fully integrated pharmaceutical Research & Development platform serving China and overseas pharmaceutical companies, assisting on drug discovery, pre-clinical and early clinical-stage development, while also expanding capabilities downstream to late clinical-stage development and commercial manufacturing.

The Zhong Lun team was led by partners Hu Tingfeng and Wang Chuan; the OMM team was led by partners Portia Ku, Zhu Ke and Edwin Kwok; the JunHe team was led by partner Wang Yi, with assistance from partner Sun Xiaojia; and the Skadden team was led by partners Julie Gao and Paloma Wang.

The Joint Sponsors are Goldman Sachs, CLSA and Orient Capital.

 

To contact the editorial team, please email ALBEditor@thomsonreuters.com. 

Related Articles

Deals

N&A, S&C, TMI advise as Japan's Nidec makes $1.6 bln bid for Makino Milling

by Asian Legal Business《亚洲法律杂志》 |

TMI Associates, Freshfields and Davis Polk & Wardwell have represented Japanese manufacturing giant Nidec on its 257-billion-yen ($1.6 billion) bid for Makino Milling Machine, which turned to Nishimura & Asahi and Sullivan & Cromwell for advice.

Deals

N&A, MHM, Skadden, STB guide JX Advanced Metal’s $3 bln Japan IPO

by Nimitt Dixit |

Nishimura & Asahi and Skadden Arps Slate Meagher & Flom are advising JX Advanced Metals on its upcoming 460-billion-yen ($3 billion) initial public offering, the largest listing in Japan since SoftBank Corp’s $23.5 billion IPO in 2018.

Deals

Trilegal, Touchstone, CAM act on Carlyle’s $400 mln entry into India auto-components space

by Nimitt Dixit |

Trilegal has advised global private equity firm Carlyle on its acquisition of majority stakes in Highway Industries (HIL) and Roop Automotives for $400 million, marking its entry into India's auto components sector through a new manufacturing platform.